国家: 美国
语言: 英文
来源: NLM (National Library of Medicine)
HYDROCORTISONE ACETATE (UNII: 3X7931PO74) (HYDROCORTISONE - UNII:WI4X0X7BPJ)
Acella Pharmaceuticals, LLC
HYDROCORTISONE ACETATE
HYDROCORTISONE ACETATE 25 mg in 1 g
PRESCRIPTION DRUG
unapproved drug other
HYDROCORTISONE ACETATE PRAMOXINE HCL- HYDROCORTISONE ACETATE PRAMOXINE HCL ACELLA PHARMACEUTICALS, LLC _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- HYDROCORTISONE ACETATE 2.5%-PRAMOXINE HCL 1% CREAM KIT RX ONLY DESCRIPTION: Hydrocortisone Acetate 2.5%-Pramoxine HCl 1% Cream is a topical preparation containing Hydrocortisone Acetate 2.5% w/w and Pramoxine HCl 1% w/w in a hydrophilic base containing purified water, cetostearyl alcohol, mineral oil, white petrolatum, propylparaben, triethanolamine laurel sulfate, citric acid, sodium citrate, isopropyl palmitate, stearic acid, lanolin alcohol, methyl paraben, potassium sorbate, sorbic acid, PEG-40 stearate and ceresin wax. Topical corticosteroids are anti- inflammatory and anti-puritic agents. The structural formula, the chemical name, molecular formula and molecular weight for active ingredients are presented below. CLINICAL PHARMACOLOGY: Topical corticosteroids share anti-inflammatory, anti-pruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man. Pramoxine hydrochloride is a topical anesthetic agent which provides temporary relief from itching and Pramoxine hydrochloride is a topical anesthetic agent which provides temporary relief from itching and pain. It acts by stabilizing the neuronal membrane of nerve endings with which it comes into contact. PHARMACOKINETICS : The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier and the use of occlusive dressings. 阅读完整的文件